GBP/USD 1.374 EUR/GBP 0.858 GBP/JPY 197.544 EUR/USD 1.179 GBP/AUD 2.089 USD/JPY 143.771 USD/CAD 1.365 AUD/USD 0.658 CAD/JPY 105.357 EUR/CAD 1.609 GBP/CAD 1.875 AUD/CAD 0.897 AUD/JPY 94.549 AUD/NZD 1.079 EUR/AUD 1.793 GBP/USD 1.374 EUR/GBP 0.858 GBP/JPY 197.544 EUR/USD 1.179 GBP/AUD 2.089 USD/JPY 143.771 USD/CAD 1.365 AUD/USD 0.658 CAD/JPY 105.357 EUR/CAD 1.609 GBP/CAD 1.875 AUD/CAD 0.897 AUD/JPY 94.549 AUD/NZD 1.079 EUR/AUD 1.793
CURRENCY .wiki

Finance News – Nvo

What is your interest today?

Quartz • May 30, 2025

How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race

Despite its initial leadership in the growing weight loss medication sector, Novo Nordisk has recently experienced a decline in market share compared to Eli Lilly, affecting its fi...

Read Full Article →
Quartz • May 20, 2025

Noom is offering smaller doses of compounded Wegovy for weight loss

By introducing reduced-strength compounded Wegovy, Noom aims to capture a broader customer base while addressing cost concerns in the expanding weight management industry.

Read Full Article →
Quartz • May 16, 2025

Novo Nordisk's CEO is out after the Ozempic maker's stock dropped 50% in a year

Novo Nordisk announced that its CEO, Lars Fruergaard Jørgensen, will resign following a significant decline in the company’s market value linked to challenges faced by its key diab...

Read Full Article →
Quartz • May 12, 2025

Eli Lilly's Zepbound beat Novo Nordisk’s Wegovy in a big weight loss drug study

The superior results of Eli Lilly’s medication compared to Novo Nordisk’s in the recent trial may influence market dynamics and investor confidence within the competitive obesity t...

Read Full Article →